Global public health problem of sudden cardiac death

Rahul Mehra1

  • 1Medtronic, Inc, Minneapolis, MN, USA. rahul.mehra@medtronic.com

Insights

Sudden cardiac death (SCD) is a major global health crisis, often caused by ventricular tachyarrhythmias. While implantable cardioverter-defibrillators (ICDs) are effective, their cost limits use in developing nations, necessitating alternative strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Medical Technology

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality, responsible for 17 million deaths annually.
  • Sudden cardiac death (SCD), primarily due to ventricular tachyarrhythmias, accounts for 40-50% of CVD deaths, with survival rates below 1% globally.
  • While prevention strategies have reduced mortality in developed countries, a significant global burden remains, highlighting the need for complementary SCD management approaches.

Purpose of the Study:

  • To address the global burden of sudden cardiac death (SCD).
  • To explore complementary and alternative strategies for SCD management beyond traditional implantable cardioverter-defibrillators (ICDs).
  • To compare the efficacy and cost-effectiveness of various SCD management options across different geographical regions.

Main Methods:

  • Review of clinical trial data on implantable cardioverter-defibrillators (ICDs) for high-risk patients.
  • Analysis of the role of Automatic External Defibrillators (AEDs) and Emergency Medical Response Services in SCD management.
  • Comparative assessment of different SCD management strategies, considering geographical variations in healthcare spending and device accessibility.

Main Results:

  • Implantable cardioverter-defibrillators (ICDs) are proven to improve mortality in patients at high risk of ventricular tachyarrhythmias.
  • Low implant rates of ICDs in developing economies due to high costs and limited healthcare spending.
  • Automatic External Defibrillators (AEDs) and enhanced emergency response services present viable complementary or alternative strategies for SCD management.

Conclusions:

  • Despite proven efficacy, the high cost of ICDs restricts their widespread use in developing nations.
  • AEDs and improved emergency medical services offer promising avenues for broader SCD management and improved survival rates globally.
  • Further research is needed to compare the cost-effectiveness of ICDs versus AED-based strategies for diverse healthcare settings.

Related Concept Videos

Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...